THE EFFECT OF COLD APPLICATION ON THE DEVELOPMENT OF PHLEBITIS IN PATIENTS RECEIVING INTRAVENOUS AMIODARONE TREATMENT.
NCT05058053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-04-17
Summary
This study, which has a quasi-experimental, prospective, and open-label randomized controlled design, was conducted to examine the effect of cold application on the development of phlebitis in patients receiving IV amiodarone infusion treatment.
Study Hypotheses H0-1: There is no difference in the rate of development of phlebitis between the patients who received and who did not receive cold application during amiodarone IV infusion.
H0-2: There is no difference in the grade of phlebitis between the patients who received and who did not receive cold application during amiodarone IV infusion.
H0-3: There is no difference in the time of development of phlebitis between the patients who received and who did not receive cold application during amiodarone IV infusion.
Conditions
- Phlebitis
Interventions
- OTHER
-
Cold application
Cold application was applied a total of 12 times on the infused PVC with cold gel packs for 15 minutes at 2-hour intervals.
Sponsors & Collaborators
-
Saglik Bilimleri Universitesi
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2021-03-01
- Completion
- 2021-03-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Giant Cell Arteritis: Comparison Between Two Standardized Corticosteroids Tapering
NCT04012905 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
NCT04509219 ·Status: UNKNOWN ·Phase: PHASE1
-
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
NCT02280902 ·Status: COMPLETED
-
Withdrawal of Colchicine in Behçet Syndrome
NCT06146192 ·Status: NOT_YET_RECRUITING
-
MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN
NCT05495893 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
NCT05917561 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Sacroiliac Joint Injection on Bone Marrow Edema
NCT04895228 ·Status: UNKNOWN ·Phase: NA
-
Ozone Therapy in Ankylosing Spondylitis
NCT05429801 ·Status: COMPLETED ·Phase: NA
-
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
NCT03371095 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
NCT00302549 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
NCT05843968 ·Status: RECRUITING ·Phase: PHASE2
-
Plasmapheresis Before Rituximab in Cryoglobulinemia
NCT04692363 ·Status: UNKNOWN
-
Micophenolate Mofetil Versus Azathioprine in Myocarditis
NCT05237323 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)
NCT04161898 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Alemtuzumab for ANCA Associated Refractory Vasculitis
NCT01405807 ·Status: UNKNOWN ·Phase: PHASE4
-
Detection of Subclinical Enthesitis by Ultrasonography
NCT04209894 ·Status: COMPLETED
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Use of Prophylactic Antibiotics in Isolated Blowout Fractures
NCT01504568 ·Status: WITHDRAWN ·Phase: NA
-
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy
NCT00302510 ·Status: COMPLETED ·Phase: NA
-
The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children
NCT03692416 ·Status: UNKNOWN ·Phase: PHASE3
-
Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome
NCT03540810 ·Status: UNKNOWN ·Phase: PHASE3
-
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 ·Status: COMPLETED
-
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
NCT07276087 ·Status: RECRUITING
-
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
NCT02981212 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4